Studies have shown that active fund managers routinely underperform the S&P500 index*​

Telomir Pharmaceuticals, Inc. (NASDAQ: TELO)

TELO Stock Predictions and Ratings

WSX Rating:
NOT AVAILABLE
WSX Forecast (1yr):
NOT AVAILABLE
Analyst Rating:
NOT AVAILABLE
Analyst Forecast (1yr):
NOT AVAILABLE

TELO Stock Analysis

TELO PE Ratio:

TELO PEG Ratio: Not Available

TELO Forward EPS Growth (12 month): 0.00%

TELO PS Ratio:

TELO PSG Ratio: Not Available

TELO Forward Revenue Growth (12 month): 0.00%

TELO Articles

No data was found